Duoneb Dosing in Pediatric Patients
Introduction to Pediatric Dosing
- The American Academy of Pediatrics and other medical societies recommend that Duoneb (ipratropium bromide 0.5 mg/albuterol 2.5 mg combination) is not specifically FDA-approved for pediatric use, and standard pediatric dosing involves administering the components separately rather than as a fixed-dose combination 1, 2
Recommended Approach: Separate Component Dosing
- For children under 5 years, the recommended dose is 0.63 mg/3 mL nebulized every 4-6 hours as needed for routine bronchospasm 2
- For acute exacerbations in children under 5 years, the recommended dose is 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses, then every 1-4 hours as needed 3
- For children 5-11 years, the recommended dose is 2.5 mg nebulized for weight <20 kg and 5 mg nebulized for weight >20 kg 3
Critical Clinical Considerations
- Ipratropium provides benefit primarily in the first 3 hours of severe acute exacerbations 2
- Proper delivery is essential for efficacy, and dilute in 2-3 mL saline for adequate nebulization 3
- Use oxygen as the preferred gas source for nebulization 2
- For children <4 years, use spacer with face mask for MDI delivery 2
- Budesonide suspension is compatible with albuterol and ipratropium in the same nebulizer 1